Back to search

Article

Ex vivo validation of osteogenic efficacy in a bioceramic dual drug-delivery system

2025-08-26

Abstract excerpt

<title>Abstract</title> <p> Alendronate (ALN) is widely employed against skeletal disorders, but its low oral bioavailability and prolonged skeletal retention necessitate high systemic doses that carry significant risk. The research team previously developed a novel bioceramic drug-delivery system (DDS) that sequentially releases gentamicin during the first two weeks post-implantation (with reported therapeutic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eab4f664-6dd1-5eec-ac77-549388244bf4
DOI
10.21203/rs.3.rs-7274523/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ex vivo validation of osteogenic efficacy in a bioceramic dual drug-delivery systemDOI 10.21203/rs.3.rs-7274523/v1
Select a neighboring publication to make it the new centre.